Drug General Information (ID: DDISXE5WI0)
  Drug Name Nalidixic acid Drug Info Idarubicin Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antibiotics Antineoplastics
  Structure

 Mechanism of Nalidixic acid-Idarubicin Interaction (Severity Level: Minor)
     Altered intestinal mucosa Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Nalidixic acid Idarubicin
      Mechanism Absorption affected by changes in intestinal mucosa Alteration of intestinal mucosa
      Key Mechanism Factor 1
Factor Name Intestinal mucosa
Factor Description Intestinal mucosal barrier function is the ability of the intestine to adequately contain microorganisms and molecules in the lumen while maintaining the ability to absorb nutrients. The absorption of drugs may be altered when the intestinal mucosa is disrupted.
      Mechanism Description
  • Decreased absorption of Nalidixic acid due to intestinal mucosa variation caused by Idarubicin 

References
1 Johnson EJ, MacGowan AP, Potter MN, et al "Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy." J Antimicrob Chemother 25 (1990): 837-42. [PMID: 2373666]